Human Metabolome Technologies, Inc. Stock
Equities
6090
JP3794530000
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
671 JPY | -1.61% | -4.28% | +4.84% |
Sales 2022 | 1.22B 7.91M | Sales 2023 | 1.3B 8.4M | Capitalization | 4.42B 28.62M |
---|---|---|---|---|---|
Net income 2022 | 267M 1.73M | Net income 2023 | 285M 1.84M | EV / Sales 2022 | 2.48 x |
Net cash position 2022 | 1.27B 8.23M | Net cash position 2023 | 1.43B 9.25M | EV / Sales 2023 | 2.31 x |
P/E ratio 2022 |
16.1
x | P/E ratio 2023 |
15.5
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
1.34% | Free-Float | 80.56% |
1 day | -1.61% | ||
1 week | -4.28% | ||
Current month | +2.44% | ||
1 month | +5.67% | ||
3 months | +0.45% | ||
6 months | -2.04% | ||
Current year | +4.84% |
Managers | Title | Age | Since |
---|---|---|---|
President | 55 | 18-02-28 | |
Tomomi Ishihara
ADM | Chief Administrative Officer | - | - |
Takaomi Fukuhara
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yasuhiro Ohata
BRD | Director/Board Member | 59 | 20-06-30 |
Corporate Officer/Principal | 49 | 05-06-30 | |
Toshio Nagae
BRD | Director/Board Member | 80 | 17-06-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 671 | -1.61% | 22 000 |
24-04-18 | 682 | +0.89% | 3,300 |
24-04-17 | 676 | -1.31% | 6,000 |
24-04-16 | 685 | -0.72% | 7,700 |
24-04-15 | 690 | -1.57% | 11,500 |
Delayed Quote Japan Exchange, April 19, 2024 at 02:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+4.84% | 26.1M | |
-1.52% | 41.35B | |
+41.65% | 40.38B | |
+3.31% | 39.05B | |
-12.11% | 26.67B | |
+2.03% | 24.07B | |
-23.64% | 18.36B | |
-3.36% | 11.68B | |
+21.32% | 11.6B | |
+7.53% | 11.15B |
- Stock Market
- Equities
- 6090 Stock